Focus Care & Axxelent Partner For Generic Drug Development In Dutch, EU Markets
Contract Pharmaceutical R&D facility is fully functional wrt to Oral Solid Dosage forms and Injectable.
Ground breaking for our Phase 2 expansion in the Manufacturing facility completed on October 9th, 2021
Inclusion Of orals liquids and semi-solids
Commercial facility